The Regulation of Hybrids and Chimeras in the UK

Beyleveld, D.; Finnegan, T.; Pattinson, Shaun D.

doi:10.1007/978-3-540-93869-9_25

The Regulation of Hybrids and Chimeras in the UK

Beyleveld, D.; Finnegan, T.; Pattinson, Shaun D.

Authors

Professor Deryck Beyleveld deryck.beyleveld@durham.ac.uk
Professor

T. Finnegan

Professor Shaun Pattinson s.d.pattinson@durham.ac.uk
Professor

Contributors

J. Taupitz
Editor

M. Weschka
Editor

Abstract

In this report, we will, for the most part, sidestep discussion of how “chimeras” and “hybrids” are to be defined and distinguished, by simply focusing on the UK’s regulation of the activities that CHIMBRIDS has identified as its concern. These are activities that involve “the fusion of human and non-human tissue and cells”, and include human/non-human: * transplantation (i.e. xenotransplantation) * gamete mixing * somatic cell nuclear transfer (into an enucleated ovum) * zygote genetic modification * embryonic cell transfer/fusion. We will address each of these possibilities before addressing patent regulation and the wider ethico-cultural background of the UK regulatory position.

Citation

Beyleveld, D., Finnegan, T., & Pattinson, S. D. (2009). The Regulation of Hybrids and Chimeras in the UK. In J. Taupitz, & M. Weschka (Eds.), Chimbrids : chimeras and hybrids in comparative European and international research : scientific, ethical, philosophical and legal aspects (603-825). Springer Verlag. https://doi.org/10.1007/978-3-540-93869-9_25

Publication Date	Jan 1, 2009
Deposit Date	Jan 26, 2012
Publicly Available Date	Sep 11, 2012
Publisher	Springer Verlag
Pages	603-825
Series Title	Veröffentlichungen des Instituts für Deutsches, Europäisches und Internationales Medizinrecht, Gesundheitsrecht und Bioethik der Universitäten Heidelberg und Mannheim
Book Title	Chimbrids : chimeras and hybrids in comparative European and international research : scientific, ethical, philosophical and legal aspects.
Chapter Number	Annex A.III.2
DOI	https://doi.org/10.1007/978-3-540-93869-9_25